Bolder Surgical

The company's business model revolves around the development, manufacturing, and sale of advanced energy vessel sealing and dissection tools. Its products are distributed across the United States and internationally to hospitals and surgical centers. The acquisition by Hologic provided Bolder with access to a vast commercial channel and established relationships with OB/GYN specialists, creating a substantial growth opportunity. Prior to the acquisition, Bolder Surgical was projected to generate around $10 million in revenue for the 2021 calendar year.

Bolder Surgical's product line is distinguished by its focus on creating combination devices that enhance surgical efficiency by reducing the need for instrument exchanges. Key products include the CoolSeal™ Vessel Sealing platform, which features advanced bipolar radiofrequency (RF) technology. This platform includes the 3mm CoolSeal Mini™ vessel sealer and the 5mm CoolSeal Trinity™, a multifunctional instrument designed for dissection, vessel sealing, and dividing. These devices are noted for their slender, dual-action jaws and minimal thermal spread, which is crucial when operating near delicate structures. Another core offering is the JustRight® line, which includes a 3 mm vessel sealer and a 5 mm stapler, both created for procedures in confined surgical spaces.